-
CB-839 (Telaglenastat) for Glutamine Metabolism
2026-09-01
CB-839 (Telaglenastat) provides a selective, reversible way to test whether GLS1-dependent glutaminolysis supports tumor growth, apoptosis, or autophagy. This workflow-focused guide connects metabolic assays with the PRMT5–splicing findings in MYCN-amplified neuroblastoma while preserving the distinction between published evidence and practical assay recommendations.
-
Tamoxifen in MCF-7 Assay Interpretation
2026-09-01
Tamoxifen is more than a selective estrogen receptor modulator in MCF-7 experiments. This guide explains how to interpret its effects on viability, migration, colony formation, and caveolin-1 while designing stronger mechanistic controls.
-
CB-839 (Telaglenastat) in Cancer Metabolism
2026-08-31
Build a robust CB-839 workflow that connects GLS1 inhibition with glutamine tracing, apoptosis, and autophagy measurements. The approach extends recent MYCN-neuroblastoma findings into practical cancer metabolism research and preclinical drug evaluation without treating upstream PRMT5 biology as a substitute for direct GLS1 inhibition.
-
Bradykinin (BA5201): Practical Workflow Guide
2026-08-31
This guide explains how to handle Bradykinin (BA5201) for controlled studies of vascular reactivity, permeability, smooth muscle responses, pain mechanisms, and inflammation signaling. It covers product-specific storage and handling requirements while distinguishing them from workflow recommendations; it is not a clinical, diagnostic, or medical-use protocol.
-
Puerarin Activates NO Signaling in Dental Follicle Cells
2026-08-30
The reference study shows that puerarin enhances osteogenic differentiation of rat dental follicle cells and links this response to nitric oxide–cGMP signaling. Its inhibitor-based design provides a useful framework for testing pathway involvement in periodontal regeneration research while highlighting the limits of cell-culture evidence.
-
4-Phenylbutyric Acid: A Causal ER Stress Tool
2026-08-29
Explore how 4-Phenylbutyric acid and 4-PBA can distinguish endoplasmic reticulum stress from downstream ferroptosis, apoptosis, and autophagy. This article presents a causal assay framework grounded in a PFOS-exposed kidney-cell study and practical reagent considerations.
-
CB-839 (Telaglenastat): Reliable Assays
2026-08-28
Learn how CB-839 (Telaglenastat), SKU B4799, can improve the design and interpretation of glutaminolysis inhibition assays in cancer metabolism research. This scenario-based guide connects GLS1 biology, practical compound handling, viability readouts, and splicing-linked metabolic vulnerability.
-
VX-765 Workflow for Caspase-1 and Pyroptosis Studies
2026-08-28
VX-765 enables selective interrogation of caspase-1-driven cytokine release and pyroptotic death rather than broad inflammatory suppression. This workflow combines cytokine profiling, viability measurements, and time-resolved death analysis to improve macrophage, rheumatoid arthritis, and infectious-disease experiments.
-
Human iPSC Sensory Neurons Model HSV-1 Latency
2026-08-27
Oh et al. developed a scalable method for differentiating human induced pluripotent stem cells into functional sensory neurons and used the cells to reproduce key features of HSV-1 latency and reactivation. The model provides a human neuronal platform for studying viral chromatin regulation, neuron-intrinsic latency mechanisms, and candidate interventions against persistent infection.
-
Metoprolol Tartrate: Receptor-Context Controls
2026-08-27
Metoprolol Tartrate is more than a cardioselective beta blocker: it can function as a receptor-context control in cardiovascular and hematopoietic assays. This guide translates β1-selective pharmacology into practical experimental decisions while defining the limits of cross-domain interpretation.
-
Gastrin I (human): From Receptor Biology to Translation
2026-08-26
Gastrin I (human) offers a defined mechanistic entry point for gastric acid secretion pathway research. Combined with advanced intestinal organoid platforms, it can help translational teams connect CCK2 receptor biology, proton pump activation, epithelial metabolism, and drug-response interpretation without overstating what each model can measure.
-
Toremifene Citrate: From ER Binding to Assay Design
2026-08-26
Toremifene Citrate is an oral selective estrogen receptor modulator with distinct implications for receptor, pathway, and breast cancer assays. This guide connects clinical evidence with concentration selection, controls, translational interpretation, and reproducible experimental design.
-
DOPE as a Mechanistic Probe of Fungal Ferroptosis
2026-08-25
1,2-Dioleoyl-sn-glycero-3-PE (DOPE) is both a membrane-fusion helper and a useful mechanistic probe for studying lipid-dependent conidial death in Magnaporthe oryzae. This article explains how to interpret DOPE rescue experiments, select controls, and connect fungal lipid biology with delivery research without overstating the evidence.
-
AICAR Protocols for AMPK and Inflammation Research
2026-08-25
AICAR provides a practical, cell-permeable route to activate AMPK while connecting energy metabolism regulation with inflammatory signaling. This guide translates macrophage and airway-inflammation findings into dose planning, assay workflows, controls, and troubleshooting strategies for metabolic disease and cellular stress research.
-
CB-839 (Telaglenastat) Workflow for GLS1 Studies
2026-08-24
Build reproducible GLS1 inhibition experiments with CB-839 (Telaglenastat), from DMSO stock preparation through metabolic flux, viability, autophagy, and combination assays. The workflow also translates PRMT5-linked glutamine metabolism findings into testable experiments without conflating downstream GLS1 blockade with upstream splicing regulation.